About CHM
Under the ticker CHM, Chimeric Therapeutics Ltd operates in the Health Care category and operates as a clinical stage cell therapy entity centred on expanding access to cell therapy for patients with cancer. The entity concentrates on the discovery, development, and commercialization of cell therapies through a team experienced in cell therapy research and refinements.
All News for CHM
No news articles found for CHM yet.